ES2183146T3 - Composiciones contra la malaria que contienen derivados cis-fusionados de ciclopenteno-1,2,4-trioxano. - Google Patents

Composiciones contra la malaria que contienen derivados cis-fusionados de ciclopenteno-1,2,4-trioxano.

Info

Publication number
ES2183146T3
ES2183146T3 ES97910531T ES97910531T ES2183146T3 ES 2183146 T3 ES2183146 T3 ES 2183146T3 ES 97910531 T ES97910531 T ES 97910531T ES 97910531 T ES97910531 T ES 97910531T ES 2183146 T3 ES2183146 T3 ES 2183146T3
Authority
ES
Spain
Prior art keywords
fusionate
trioxan
cyclopentene
derivatives
compositions against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97910531T
Other languages
English (en)
Inventor
Wallace Peters
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmamar SA
Original Assignee
Pharmamar SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmamar SA filed Critical Pharmamar SA
Application granted granted Critical
Publication of ES2183146T3 publication Critical patent/ES2183146T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

EL OBJETO DE ESTA INVENCION ES UNA COMBINACION DE MEDICAMENTOS ANTIPALUDICOS, QUE ESTA DESTINADA AL TRATAMIENTO PREVENTIVO O CURATIVO DEL PALUDISMO Y QUE CONTIENE UN PRIMER COMPONENTE, EL FENOZAN, QUE ES UN CIS - FUSIONADO CICLOPENTENO - 1, 2, 4, TRIOXANO, Y UN SEGUNDO COMPONENTE QUE ES OTRO MEDICAMENTO ANTIPALUDICO.
ES97910531T 1996-10-28 1997-10-28 Composiciones contra la malaria que contienen derivados cis-fusionados de ciclopenteno-1,2,4-trioxano. Expired - Lifetime ES2183146T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9622427.4A GB9622427D0 (en) 1996-10-28 1996-10-28 Antimalarial drugs

Publications (1)

Publication Number Publication Date
ES2183146T3 true ES2183146T3 (es) 2003-03-16

Family

ID=10802068

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97910531T Expired - Lifetime ES2183146T3 (es) 1996-10-28 1997-10-28 Composiciones contra la malaria que contienen derivados cis-fusionados de ciclopenteno-1,2,4-trioxano.

Country Status (15)

Country Link
US (1) US5834505A (es)
EP (1) EP0938306B1 (es)
JP (1) JP2001507672A (es)
AT (1) ATE224709T1 (es)
AU (1) AU738885B2 (es)
CA (1) CA2270138A1 (es)
DE (1) DE69715895T2 (es)
DK (1) DK0938306T3 (es)
ES (1) ES2183146T3 (es)
GB (1) GB9622427D0 (es)
IL (1) IL129635A (es)
NZ (1) NZ335451A (es)
OA (1) OA11039A (es)
PT (1) PT938306E (es)
WO (1) WO1998018462A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN191696B (es) * 1999-02-12 2003-12-20 Council Scient Ind Res
EP1261340B1 (en) 1999-07-13 2009-05-13 Alpha Research Group, LLC Compositions and methods for the treatment of parkinson's disease
US20040229908A1 (en) * 1999-07-13 2004-11-18 Jodi Nelson Compositions and methods for the treatment of Parkinson's disease and tardive dyskinesias
US8784881B2 (en) * 2004-03-05 2014-07-22 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of diseases
EP2200611A4 (en) 2007-09-14 2010-09-22 Biogen Idec Inc COMPOSITIONS AND METHODS FOR TREATING PROGRESSIVE MULTIFOCALER LEUKOENCEEPHALOPATHY (PML)
US20180055835A1 (en) 2016-08-25 2018-03-01 Immune Therapeutics Inc. Method for Treating And Preventing Protozoal Infections
KR102491180B1 (ko) 2017-04-27 2023-01-20 파르마 마르 에스.에이. 항종양 화합물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH672734A5 (es) * 1987-04-03 1989-12-29 Charles W Jefford
IN166154B (es) * 1987-05-08 1990-03-24 Hoechst India
SU1689336A1 (ru) * 1989-05-03 1991-11-07 Akhmedzyanov Maksut M Композици дл изготовлени строительных материалов
NZ246606A (en) * 1992-02-07 1995-09-26 Ciba Geigy Ag Antimalarial compostions containing a synergistic combination of benflumetol and quinine or a derivative thereof

Also Published As

Publication number Publication date
US5834505A (en) 1998-11-10
IL129635A (en) 2002-05-23
GB9622427D0 (en) 1997-01-08
EP0938306A1 (en) 1999-09-01
IL129635A0 (en) 2000-02-29
PT938306E (pt) 2002-12-31
AU4788097A (en) 1998-05-22
CA2270138A1 (en) 1998-05-07
NZ335451A (en) 2001-02-23
JP2001507672A (ja) 2001-06-12
AU738885B2 (en) 2001-09-27
DE69715895T2 (de) 2003-07-31
DE69715895D1 (de) 2002-10-31
EP0938306B1 (en) 2002-09-25
OA11039A (en) 2003-03-07
WO1998018462A1 (en) 1998-05-07
DK0938306T3 (da) 2003-01-13
ATE224709T1 (de) 2002-10-15

Similar Documents

Publication Publication Date Title
CY1120313T1 (el) Φαρμακευτικη συνθεση για δερματικη χρηση για να θεραπευεται ψωριαση που περιλαμβανει βιταμινη d και κορτικοστεοειδες
HUP9900962A2 (hu) Fertőtlenítőkészítmények és eljárások felületek fertőtlenítésére
GT199700009AA (es) Terapia combinada para la osteoporosis
BR9810985A (pt) Aplicação tópica de uma combinação de peróxido de benzoìla e um segundo ingrediente ativo
BR0207961A (pt) Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas
PT100963A (pt) Composicoes farmaceuticas para aplicacao topica de elevada penetracao atraves da pele que compreendem certos polimeros nao-ionicos especificos
BR9908474A (pt) Preparação de liberação prolongada, processo para a produção de uma preparação de liberação prolongada, e, composição farmacêutica
BR9808703A (pt) Composição que fornece medicamento solúvel emágua de dissolução relativamente lenta e usosublingual
CO5011043A1 (es) Composicion farmaceutica que contiene un compuesto inhibidor ace y estabilizador, tabletas que la contienen y proceso para estabilizar inhibidores de ace
MX168330B (es) Composicion biocida
BR9810197A (pt) Produto, compostos, processo de preparação destes, composição farmacêutica, e, utilização de um produto
BR9808427A (pt) Produto, processo de preparação e utilização do mesmo e composição farmacêutica
BR9810520A (pt) Inibidor do fator xa isolado ou em combinação com um anti-agregador plaquetário, contra a trambose arterial
ES2183146T3 (es) Composiciones contra la malaria que contienen derivados cis-fusionados de ciclopenteno-1,2,4-trioxano.
BR0315139A (pt) Agentes antibacterianos de tetraidroquinolina tricìclica
SE9604348D0 (sv) Användning av hydroxyguanidiner
EP1132093A4 (en) PREVENTIVE OR REMEDIAL AGAINST MYOCARDITIS, DILATED CARDIOMYOPATHY, AND HERZIN SUFFICIENTS CONTAINING NF-KAPPA B INHIBITORS AS AN ACTIVE INGREDIENT
ES2181017T3 (es) Composicion farmaceutica que contiene una sustancia promotora de osteogenesis y un polietilenglicol.
EP0856315A4 (en) MEDICINAL COMPOSITION
BR0010546A (pt) Terapia antiinflamatória para infecção mediada inflamatória
BR9911917A (pt) Composições compreendendo análogos de gaba e cafeìna
ES2041243T3 (es) Aplicacion de por lo menos un principio activo inhibidor o destructor de por lo menos un ser vivo unicelular o virus.
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
BR9713537A (pt) omo agonistas a alfa-2-adrenorreceptor
BR0206775A (pt) Uso de um medicamento para tratar um indivìduo infectado com hiv, por combinação de imunização com interrupção estruturada do tratamento anti-retrovirótico